Endoscopic ultrasound guided fine needle biopsy in patients with suspected gastric linitis plastica

•The infiltrative character of gastric linitis plastica (GLP) lead to a late diagnosis and non-conclusive mucosal biopsies.•We revealed that lymph node or gastric parietal biopsies guided by EUS in the setting of suspected gastric cancer have a considerable high sensitivity.•EUS-FNB could be propose...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinics and research in hepatology and gastroenterology 2022-05, Vol.46 (5), p.101903-101903, Article 101903
Hauptverfasser: Assaf, Antoine, Terris, Benoit, Palmieri, Lola-Jade, Rouquette, Alexandre, Beuvon, Frédéric, Pellat, Anna, Ali, Einas Abou, Ginestet, Claire, Belle, Arthur, Dhooge, Dr Marion, Brezault, Dr Catherine, Hallit, Rachel, Dohan, Anthony, Chaussade, Stanislas, Coriat, Romain, Barret, Maximilien
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•The infiltrative character of gastric linitis plastica (GLP) lead to a late diagnosis and non-conclusive mucosal biopsies.•We revealed that lymph node or gastric parietal biopsies guided by EUS in the setting of suspected gastric cancer have a considerable high sensitivity.•EUS-FNB could be proposed early in the diagnostic workup instead of repeating mucosal biopsies. Gastric linitis plastica (GLP) is a diffuse infiltrating type of gastric adenocarcinoma. It is associated with a poor prognosis and a five-year survival of 3–10%. The infiltrating profile of this tumor explains the low yield of the superficial mucosal biospies. The objective of this study was to investigate the role of endoscopic ultrasound-fine needle biopsy (EUS-FNB) in the diagnosis of GLP. We performed a retrospective analysis including all patients who had an EUS-FNB, at a tertiary referral center, over the last 3 years. The primary outcome was the sensitivity of EUS-FNB in patients with suspected GLP. Between January 2017 and December 2020, 34 patients had an EUS-FNB for suspected GLP. Ten patients had a diagnostic of GLP. This diagnosis was obtained by EUS-FNB in 90% (9/10) of the cases. Eight patients had at least one previous esophagogastroduodenoscopy (EGD) with negative mucosal biopsies. Gastric EUS-FNB helped diagnose other serious conditions in 47% (16/34) of cases with inconclusive mucosal biopsies. Gastric EUS-FNB in patients with suspected GLP and normal endoscopic mucosal biopsies may lead to a positive diagnosis of GLP in 90% of cases without notable adverse events. This technique should be considered as a second step in the setting of suspicion of GLP after inconclusive mucosal biopsies.
ISSN:2210-7401
2210-741X
DOI:10.1016/j.clinre.2022.101903